Healthcare AI Governance Committee Charter: Roles, Decisions and a Practical Meeting Agenda

Author: Eunoia Consulting Co. | Published: September 30, 2026

An evidence-led healthcare AI governance committee charter: how to define decision rights, accountable roles, review inputs, escalation routes and a repeatable meeting agenda without turning oversight into a launch bottleneck.

Healthcare organisations do not need a large committee to begin governing AI. They do need a clear way to decide what is in scope, who can accept or escalate risk, what evidence is required before a decision, and how concerns remain visible after a system goes live.

A governance committee charter can provide that operating structure. It is not a promise that an AI system is safe, compliant or suitable for every setting. It is a written agreement about how leaders will make, document and revisit decisions about AI-enabled workflows in their own organisation.

This article offers a practical starting point for hospitals, health systems, physician groups and healthcare operators. It draws on the voluntary NIST AI Risk Management Framework and its governance guidance, while recognising that each organisation must determine the legal, clinical, privacy, security and contractual requirements that apply to its use case.

Start with the committee's decision rights

A committee becomes a bottleneck when its purpose is vague. It becomes useful when people can state the decisions it owns and the decisions it only advises on.

A charter should name the committee's authority in plain language. For example, it may be authorised to:

• maintain the organisation's inventory of AI-enabled systems and intended uses;
• classify proposed uses for the depth of clinical, operational, privacy, security and procurement review they need;
• decide whether a proposal can proceed, proceed with conditions, be deferred or be declined;
• approve a documented set of implementation conditions before a material workflow begins;
• receive material change notices, incidents, exceptions and review findings; and
• escalate decisions that require executive, legal, compliance, clinical or board-level authority.

It should not silently absorb responsibilities held elsewhere. A clinical safety review, information-security approval, privacy assessment, contract signature or medical-staff decision may remain with its established accountable owner. The committee's job is to make the dependencies visible, not to replace specialist authority with a meeting.

The NIST AI RMF Playbook's GOVERN function emphasises documented roles, responsibilities and communication lines for mapping, measuring and managing AI risk. That is a useful design test for a charter: can an employee tell who decides, who advises, who carries out the action, and where an unresolved concern goes next?

Build a cross-functional group around the workflow

There is no universal membership list. The appropriate mix depends on the AI system's intended use, data, users and decision consequences. A lean core committee may include an executive sponsor, clinical or operational leader, privacy and security representation, technology or data leadership, procurement or vendor-management representation, and a person responsible for documenting decisions.

Bring in additional expertise when the proposal warrants it. Examples include legal counsel, quality and safety, compliance, revenue-cycle leadership, nursing or practice operations, accessibility, human factors, patient experience and workforce or training leads. The important distinction is between standing accountability and needed expertise for a particular decision.

The charter should make conflict handling explicit. A product owner, vendor manager or implementation lead can provide essential context, but a decision should not depend solely on the people most invested in a launch. NIST's governance guidance specifically notes the value of structures that allow decisions to be questioned and course-corrected, including separation between development and testing functions where appropriate.

Define a repeatable decision packet

A committee cannot compare proposals if every team brings a different slide deck. Use one short decision packet with a predictable set of questions:

• What is the intended use? State the user, the workflow step, the output, and the action the output may influence. Name out-of-scope use as well.
• What data and interfaces are involved? Describe inputs, outputs, logging, retention, access, integrations, subprocessors and any transfer boundaries that must be assessed.
• What is the human role? Explain who reviews, may override, may rely on, or must not use the output. Include training and escalation expectations.
• What evidence has been reviewed? Record the artefact, date, source, limitations and local relevance. Do not turn a vendor statement into a conclusion merely by attaching it.
• What could go wrong in this workflow? Capture foreseeable clinical, operational, privacy, security, equity, safety, financial and reputational concerns without assuming each applies equally.
• What conditions must be met before use? Assign an owner and due date to each open item, such as testing, contract language, user training, monitoring or an incident route.
• How will the decision be revisited? Define a trigger: a material vendor release, changed intended use, incident, new interface, data change, concerning feedback or a scheduled review date.

For AI or predictive algorithms used within certified health IT, ONC's HTI-1 Final Rule establishes algorithm-transparency requirements within the ONC Health IT Certification Program. The rule is not a substitute for local governance. It is, however, a reason to ensure that a committee asks what information users can access about the algorithm and how that information informs a local decision about fairness, appropriateness, validity, effectiveness and safety.

Use four possible decisions, not a single yes or no

A simple decision vocabulary reduces ambiguity in minutes and follow-up work:

| Decision | Meaning | Required record | |---|---|---| | Proceed | The committee has sufficient evidence for the defined use, subject to named operating owners. | Decision date, scope, evidence reviewed, owners and next review. | | Proceed with conditions | The intended use may move forward only after specific conditions are completed and confirmed. | Conditions, owners, due dates and the evidence needed to close each item. | | Defer | The proposal needs more information, testing or a decision by a different authority. | The question to resolve, accountable owner and return date. | | Decline | The organisation will not use the system for the proposed purpose at this time. | Rationale, alternatives considered if relevant, and reconsideration trigger if any. |

The committee should be able to explain the decision without overstating certainty. A recorded decision is not a certification, legal opinion or clinical endorsement. It is evidence that the organisation considered the defined use and attached accountability to the outcome.

Establish an agenda that makes the charter operational

A monthly 60-minute session may be sufficient for a smaller portfolio; higher-volume organisations may need a more frequent working group and a separate executive escalation path. The cadence matters less than consistency.

A practical standing agenda is:

• Portfolio and changes (10 minutes): new systems, proposed uses, material releases, retired tools and ownership changes.
• Decision packets (25 minutes): one or two proposals with the decision required, evidence, open items and recommendation stated up front.
• Implementation conditions (10 minutes): items due before launch, accountable owner, current status and blockers.
• Signals and exceptions (10 minutes): incidents, user feedback, data-quality concerns, monitoring results and vendor notices that may require action.
• Actions and escalations (5 minutes): decision log updates, named owners, deadlines and external committees or executives to involve.

The meeting should produce a durable decision log, not only minutes. Each record should link the AI system or workflow to the decision, scope, evidence packet, conditions, owner, date and next review trigger. This can start as a governed register; it does not require a new software platform.

Connect the committee to day-to-day operations

A charter fails when it is isolated from procurement, implementation and incident processes. Make the hand-offs explicit.

• Before procurement: the committee can define the evidence and decision questions that vendor due diligence must answer. Use the healthcare AI procurement evidence register to connect claims to artefacts, owners and open questions.
• Before launch: implementation owners should be able to show that required conditions, training, access controls, test results and escalation routes are ready for the defined use.
• After launch: the team should know what counts as a material change and how to route it. The healthcare AI vendor change-control guide outlines a practical way to assess releases, data changes and rollback readiness.
• At review: the committee should revisit the use when triggers occur rather than relying on a calendar alone. A regular evidence-review rhythm can make oversight work visible without treating every system as identical.

At an enterprise scale, governance also benefits from clear sponsorship. HHS describes its Chief AI Officer role as leading enterprise-wide strategy for responsible adoption, governance and oversight of AI technologies. A provider organisation does not need to copy a federal operating model, but it should be clear where enterprise accountability sits and how the committee reaches it.

A one-page charter outline

A first version can fit on one page:

• Purpose: govern defined AI-enabled uses through accountable, evidence-informed decisions.
• Scope: systems, workflows, data, vendors and business units covered; explicit exclusions.
• Decision rights: proceed, proceed with conditions, defer, decline and escalate.
• Membership: standing roles, chair, decision recorder and invited subject-matter experts.
• Quorum and conflicts: minimum perspectives required; how conflicts are disclosed and managed.
• Inputs: inventory entry, decision packet, evidence register, change notice, incident or exception report.
• Outputs: decision log, conditions register, escalation record and next-review trigger.
• Cadence: meeting frequency plus an urgent route for time-sensitive concerns.
• Measures: completion of conditions, overdue actions, unresolved exceptions, portfolio changes and lessons carried into policies or training.

Keep the language suitable for the organisation's current maturity. A charter is most useful when teams can use it in a real decision next week, then improve it after the first few cases.

When to seek help

If your organisation is introducing AI into clinical, operational, revenue or patient-facing workflows, start with a focused governance working session. Eunoia Consulting Co. helps healthcare organisations design evidence-led AI governance, operating controls and implementation decision paths that fit the systems and responsibilities they already have. Explore Eunoia's AI governance advisory services or contact the team to discuss the workflow you are evaluating.

Sources

• NIST — Artificial Intelligence Risk Management Framework (AI RMF)
• NIST AI RMF Playbook — GOVERN
• ASTP/ONC — HTI-1 Final Rule: Algorithm Transparency
• HHS — Harnessing AI to Power the HHS Mission